Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation

Blood

Volumn 108, Issue 13, 2006, Pages 4288-4290

  Schmitz, Norbert ^b   Eapen, Mary ^a   Horowitz, Mary M ^b   Zhang, Mei Jie ^b   Klein, John P ^b   Rizzo, J Douglas ^b   Loberiza, Fausto R ^b   Gratwohl, Alois ^b   Champlin, Richard E ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHOTREXATE;

ACUTE LEUKEMIA; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME;

EID: 33845478320     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-05-024042     Document Type: Article

References (13)

1. Champlin RE, Schmitz N, Horowitz MM, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood. 2000;95:3702-3709.
2. Powles R, Metha J, Kulkarni S, et al. Allogeneic blood and bone marrow stem-cell transplantation in haematological malignant diseases: a randomized trial. Lancet. 2000;355:1231-1237.
3. Blaise D, Kuentz M, Fortainer C, et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Franciase de Greffe de Molle. J Clin Oncol. 2000;18:537-546.
4. Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med. 2001;344:175-181.
5. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH. Acute and chronic graft-versus-host disease after allogeneic peripheral blood stem cell and bone marrow transplantation. J Clin Oncol. 2001;19:3685-3691.
6. Schmitz N, Beksac M, Hasenclever D, et al. European Group for Blood and Marrow Transplantation. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard risk leukemia. Blood. 2002;100:761-767.
7. Couban S, Simpson DR, Barnett MJ, et al. A randomized multi-center comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood. 2002;100:1525-1531.
8. Ringden O, Labopin M, Bacigalupo A, et al. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adults with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol. 2002;20:4655-4664.
9. Schmitz N. Allogeneic peripheral blood vs. bone marrow transplantation for patients with chronic myeloid leukemia: results of an individual patient data meta-analysis [abstract]. Blood 2004;104:3320.
10. Schmitz N, Beksac M, Bacigalupo A, et al. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial. Hematologica. 2005;90:643-648.
11. Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol. 2005;23:5074-5087.
12. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-202.
13. Flowers MED, Parker PM, Johnston LJ, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow up of a randomized trial. Blood. 2002;100:415-419.